Introduction to clinical positron emission tomography.
Positron emission tomography (PET) scanning with [18F] fluorodeoxyglucose (FDG) has developed over 25 years into a valuable clinical tool used mainly for the evaluation of oncology patients. The purpose of this article is to provide an introduction to the basic scientific concepts of FDG-PET imaging as well as to illustrate its clinical utility.
['Adenocarcinoma/diagnostic imaging', 'Adult', 'Aged', 'Aged, 80 and over', 'Carcinoma, Bronchogenic/diagnostic imaging', 'Colonic Neoplasms/diagnostic imaging', 'Female', '*Fluorodeoxyglucose F18', 'Hodgkin Disease/diagnostic imaging', 'Humans', 'Lung Neoplasms/diagnostic imaging', 'Male', 'Middle Aged', '*Radiopharmaceuticals', '*Tomography, Emission-Computed']